Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 8, 2010, Pages 1053-1060

  Bjercke, Sverre ^a   Tanbo, Tom ^a   Åbyholm, Thomas ^a   Omland, Anne ^a   Opøien, Hans Kristian ^a   Fedorcsak, Peter ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

HMG; ICSI; IVF; Live birth rate; Pregnancy rate; RFSH

Indexed keywords

BUSERELIN ACETATE; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG USE; ECTOPIC PREGNANCY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MEDICAL RECORD; MULTIPLE CYCLE TREATMENT; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; BUSERELIN; EMBRYO, MAMMALIAN; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; LIVE BIRTH; MENOTROPINS; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS;

EID: 77954854466     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349.2010.499450     Document Type: Article

References (31)

1. Fevold HL. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology. 1941;28:33-36
2. Ryen KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombinant ovarian granulosa and theca cells. J Clin Endocrinol Metab. 1968;67:889-899
3. Van Wely M, Westergaard LG, Bossuyt PMM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone of ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003:CD003973.
4. Westergaard LG, Erb K, Laursen SB, Rex S, Rasmussen PE. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic sperm injection: a prospective randomized study. Fertil Steril. 2002;76:543-549
5. European and Israeli Study Group on Highly Purified Menotrophin versus Recombinant Follicle-Stimulating Hormone 2002. Efficacy and safety of highly purified menotrophins versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized comparative trial. Fertil Steril. 2002;78: 520-528
6. Platteau P, Smitz J, Albano C, Sørensen P, Arce JC, Devroey P. Exogenous luteinizing hormone may influence the treatment outcome in in vitro fertilization but not in intracytoplasmatic sperm injection cycles. Fertil Steril. 2004;81:1401-1404
7. Arce JC, Nyboe Andersen A, Collins J. Resolving methodological and clinical issues in the design of efficacy in assisted reproduction technologies: a mini-review. Hum Reprod. 2005;20:1757-1771
8. Nyboe Andersen A, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21: 3217-3227
9. Platteau P, Nyboe Andersen A, Loft A, Smitz J, Danglas P, Devroey P. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online. 2008;17:190-198
10. Coomarasamy A, Masoud A, Cheema D, van der Veen, Bossuyt PMM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23:310-315
11. Daya S. Pitfalls in the design and analysis of efficiency trials in subfertility. Hum Reprod. 2003;18:1005-1009 (Pubitemid 36592042)
12. Meldrum DR, Silverberg KM, Bustillo M, Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril. 1998;69:1005-1009
13. Hompes PGA, Broekmans FJ, Hoozemans DA, Schats R. Effectiveness of highly purified menopausal gonadotrophin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmatic sperm injection patients. Fertil Steril. 2008;89:1685-1693
14. Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulating hormone levels. Fertil Steril. 1992;57:819-824
15. Brindsen P, Akagbosu F, Gibbons LM, Lancaster S, Gourdon D, Engrand P, et al. A comparison of the efficiency and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization transfer. Fertil Steril. 2000;73:114-116
16. Veeck LL. Human oocytes at the time of follicular harvest. In: Brown C-L (ed). Atlas of the human oocyte and early conception, 1st edn. Baltimore: Williams and Wilkins, 1986. pp. 5-109.
17. Van den Abbeel E, Van der Elst J, Van Waesberghe L, Camus M, Devroey P, Khan I, et al. Hyperstimulation: the need for cryopreservation of embryos. Hum Reprod 1988;3 (Suppl 2):53-57
18. Smitz J, Nyboe Andersen A, Devroey P, Arce JC. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod. 2007;22:676-687
19. Lisi F, Rinaldi L, Fishel S, Pepe GP, Picconeri MG, Campbell A, et al. Use of recombinant FSH and recombinant LH I multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online. 2001;3:1990-1994
20. Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe GP, Picconeri MG, et al. Use of recombinant LH in a group of unselected IVF patients. Reprod Biomed Online. 2002;5: 104-108
21. De Placido GA, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxford). 2004;60: 637-643
22. Ferraretti R, Peltier E, Frydman R. Exogenous luteinization hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004;82: 1521-1526
23. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolini A, et al.; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005;20: 390-396
24. Bosch E, Pau E, Albert C, Zuzuarregui J, Remohi J, Pellicer A. Impact of different amounts of LH in controlled ovarian hyperstimulation oocyte donation cycles. Fertil Steril. 2006;86:S425.
25. Al-Inany HG, Abou-Setta AM, Anoulghar MA, Mansour RT, Serour GI. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a metaanalysis. Reprod Biomed Online. 2007;16:81-88
26. Bjercke S, Fedorcsak P, Åbyholm T, Storeng R, Ertzeid G, Oldereid N, et al. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod. 2005;20: 2441-2447
27. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867-875
28. Hofmann GE, Bergh PA, Guzman I, Masuku S, Navot D. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod. 1993;8:695-698
29. Ubaldi F, Camus M, Smitz J, Bennink HJTC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotrophin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulation hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 1996;66:275-280
30. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborelli S, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod. 2002;17: 2009-2015
31. Fanchin R, Righini C, Ayoubi J-M, Olivennes F, de Ziegler D, Frydman R. New look at endometrial echogenicity: objective computer-assisted measurement predicts endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril. 2000;74:274-281